Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Biol Int ; 45(1): 61-73, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32936498

RESUMO

Osteosarcoma (OS) is a rare malignancy of bone associated with poor clinical outcomes. The antitumor effects of GANT61 on OS is unclear. To investigate antitumor effects and mechanism of GANT61 in OS cells and xenograft model. Effects of GANT61 on cell viability, clone formation, cell cycle, apoptosis, migration, and invasion ability of OS cells were assessed. Reactive oxygen species (ROS) levels measured by dichlorofluorescein fluorescence were used to evaluate oxidative stress. The Xenograft model was constructed to investigate the antitumor effects of GANT61 in vivo. The microRNA (miRNA)-1286 was downregulated, while RAB31 upregulated in OS tissues and cells. GANT61 inhibited viability, migration, and invasion ability of OS cells (SaOS-2 and U2OS), and induced apoptosis and the ROS production, along with miRNA-1286 upregulation and RAB13 downregulation. After knockdown of miRNA-1286, GANT6-induced cell inhibition was attenuated, along with RAB31 upregulation. Inversely, miRNA-1286 overexpression downregulated RAB31. Dual-luciferase reporter assay verified that miR-1286 negatively targeted RAB13. Moreover, the knockdown of RAB31 stimulated apoptosis and ROS production while inhibited viability, migration, and invasion of GANT61-treated cells. In vivo experiments further confirmed that GANT61 inhibited tumor growth and RAB13 expression, but enhanced miRNA-1286. The study demonstrated that GANT61 inhibited cell aggressive phenotype and tumor growth by inducing oxidative stress through the miRNA-1286/RAB31 axis. Our findings provided a potential antitumor agent for the OS clinical treatment.


Assuntos
Antineoplásicos/farmacologia , MicroRNAs/metabolismo , Osteossarcoma/genética , Estresse Oxidativo/efeitos dos fármacos , Piridinas/farmacologia , Pirimidinas/farmacologia , Proteínas rab de Ligação ao GTP/metabolismo , Animais , Sequência de Bases , Linhagem Celular Tumoral , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Feminino , Regulação Neoplásica da Expressão Gênica/efeitos dos fármacos , Humanos , Camundongos Endogâmicos BALB C , Camundongos Nus , MicroRNAs/genética , Invasividade Neoplásica , Osteossarcoma/patologia , Estresse Oxidativo/genética , Ensaios Antitumorais Modelo de Xenoenxerto
2.
Zhonghua Liu Xing Bing Xue Za Zhi ; 31(3): 297-9, 2010 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-20510057

RESUMO

OBJECTIVE: To study the risk factors of human cystic echinococcosis (CE) in Hobukesar Mongolian Autonomous County of Xinjiang (HMACX) and to discuss the related strategies for prevention and control. METHODS: A randomized sampling method was used to screen local residents for human CE in HMACX. CE related risk factors including ethnicity, age, sex, occupation and personal status on hygiene etc. were analyzed under multi-factor logistic regression. RESULTS: The prevalence rates of CE and alveolar echinococcosis (AE) were 3.7% (23/627) and 0.16% (1/627) respectively, with the seropositive rate as 12.4% (76/613). The main risk factors that significantly associated with CE were age (OR = 7.6, 95%CI: 2.481 - 23.579) and slaughtering livestock in the households (OR = 3.2, 95%CI: 1.297 - 7.809). Herdsmen had the highest prevalence of CE in all of the occupations in this study. CONCLUSION: HMACX had been a highly endemic area for human CE, with age and family slaughtering-livestock-behavior appeared to be the main possible risk factors.


Assuntos
Equinococose/epidemiologia , Adolescente , Adulto , Idoso , Criança , China/epidemiologia , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Inquéritos e Questionários , Adulto Jovem
3.
J Tradit Chin Med ; 30(4): 254-8, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21287781

RESUMO

OBJECTIVE: To probe into the mechanism of the Chinese herbs with functions of reinforcing kidney and supplementing qi for preventing knee osteoarthritis of the rabbit. METHODS: Totally 72 healthy Japan long-ear white rabbits, aged 4 months, were randomly divided into 6 groups, blank group (A), model group (B), high dose Chinese herb group (C), middle dose Chinese herb group (D), small dose Chinese herb group (E), aminoglucose hydrochloride capsule control group (F), 12 rabbits in each group. All the rabbits in the groups, except the group A, were fixed with plaster cast for six weeks to establish rabbit knee osteoarthritis. At the same time of modeling, the different doses of Juanbi Capsules and aminoglucose hydrochloride capsule were administrated intragastrically in the group C, D, E, F, respectively, for 4 weeks, for preventive treatment. In the group B, the rabbit was administrated intragastrically with equal volume of normal saline to the medication groups, twice each day, in the morning and the evening, and in the group A, nothing was administrated. After modeling for 6 weeks, the joint fluid was taken and TNF-alpha, IL-1 and IL-6 contents were detected with ELISA method, and the articular cartilage was taken for macroscopic and microscopic examinations. RESULTS: In all the preventive treatment groups, the articular cartilage color changed to varying degrees with formation of osteophyte and bone cyst, superficial erosion on the chondral articular surface, and the cartilage defect reached to the mid layer in a part of specimens with cartilage exfoliation, but which in the extent were significantly lower than those in the model group. There were significant differences between the group A and B in TNF-alpha, IL-1 and IL-6 contents in the joint fluid (P < 0.05), indicating that the modeling is successful; and there were significant differences as group B compared with the group C,D, E, F, showing that TNF-alpha , IL-1 and IL-6 contents are decreased in all the medication groups; and significant differences between group C, D, E suggests that the increase of Chinese herb doses strengthened the effect of reducing TNF-alpha, IL-1 and IL-6 contents in joint fluid. CONCLUSION: The Juanbi Capsule prevents osteoarthritis possibly through decreasing serum TNF-alpha, IL-1 and IL-6 contents.


Assuntos
Medicamentos de Ervas Chinesas/administração & dosagem , Interleucina-1/imunologia , Interleucina-6/imunologia , Osteoartrite do Joelho/prevenção & controle , Líquido Sinovial/efeitos dos fármacos , Fator de Necrose Tumoral alfa/imunologia , Animais , Cápsulas , Modelos Animais de Doenças , Humanos , Articulação do Joelho/efeitos dos fármacos , Articulação do Joelho/imunologia , Masculino , Osteoartrite do Joelho/tratamento farmacológico , Osteoartrite do Joelho/imunologia , Coelhos , Distribuição Aleatória , Líquido Sinovial/imunologia
4.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 26(2): 123-4, 127, 2006 Feb.
Artigo em Chinês | MEDLINE | ID: mdl-16548351

RESUMO

OBJECTIVE: To study the clinical effect of Jieguxujin granule (JGXJG) on fracture and its effect on serum content of calcitonin gene related peptide (CGRP). METHODS: Four hundred patients with fracture were randomly divided into 2 groups, the JGXJG treated group and the control group treated with Sanqi tablet (SQT). Serum CGRP was tested with radioimmunoassay once every 3 days for 5 times, and X-ray examination was taken once each week for 10 weeks. RESULTS: The healing time of fracture and osteotylus forming time in the JGXJG group was shorter than those in the SQT group significantly (P < 0.005). Serum CGRP content in JGXJG group was higher remarkably (P < 0.05, P < 0.01). CONCLUSION: JGXJG showed evident effect in promoting union of fracture healing, it could also increase the CGRP content in serum.


Assuntos
Peptídeo Relacionado com Gene de Calcitonina/sangue , Fraturas do Fêmur/tratamento farmacológico , Consolidação da Fratura/efeitos dos fármacos , Fraturas Ósseas/tratamento farmacológico , Fitoterapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Medicamentos de Ervas Chinesas/uso terapêutico , Feminino , Humanos , Fraturas do Úmero/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Fraturas da Tíbia/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...